logo
episode-header-image
Aug 6
28m 5s

The Consumer Becomes the Payor: How ICHR...

Andreessen Horowitz, a16z Bio + Health
About this episode

In this episode, Julie Yoo and Jay Rughani are joined by Thatch cofounders Chris Ellis and Adam Stevenson to explore why ICHRA—a more recent policy innovation—might quietly revolutionize employer-sponsored health benefits. Unpacking the surprising history of how U.S. healthcare became entangled with employment, they make the case for a defined-contribution future that mirrors the rise of the 401(k) and HSA. Tailored especially for today’s distributed and fast-moving workforce, ICHRA allows employers to offer tax-free health dollars employees can spend how—and where—they choose.

 

For healthcare entrepreneurs, the conversation provides a blueprint for navigating a rapidly shifting payer landscape, including insight into how fintech infrastructure, policy tailwinds, and carrier ecosystem integrations unlock market readiness.

 

This episode was originally published in October of 2024. The conversation remains relevant today. 

Up next
Jul 22
Engaging the Unengaged at Home with Max Cohen and Cameron Behar
In this episode, Sprinter Health co-founders Max Cohen and Cameron Behar sit down with Julie Yoo to unpack how their home-based care model reaches underserved populations and reintegrates “the unengaged” into the healthcare system. From starting with blood draws in living rooms t ... Show More
22m 32s
Jun 20
Streamlining the Patient Referrals Chain with Trey Holterman
In this episode, Tennr cofounder and CEO Trey Holterman sits down with a16z’s David Haber and Jay Rughani to unpack one of healthcare’s most overlooked pain points: patient referral logistics. When a patient is referred to a specialist and told that the specialist will follow up ... Show More
19m 53s
Jun 10
From Chaos to Clarity in Data with Malinka Walaliyadde
What if one of healthcare’s most complex administrative challenges—revenue cycle management—was reframed as a data science problem? In this episode, Malinka Walaliyadde, cofounder and CEO of AKASA, joins Julie Yoo to unpack how large language models have the potential to transfor ... Show More
23m 23s
Recommended Episodes
Feb 2024
Biotech Special: a16z and the Biotech Revolution with Vijay Pande
There is a revolution unfolding in biotech. The confluence of new biological methods like CRISPR, virtually unlimited computational capacity, and machine learning has fundamentally transformed our ability to engineer biology for wide-ranging applications. Andreessen Horowitz, or ... Show More
57m 1s
Aug 2024
Reinventing AI Agents with Imbue CEO Kanjun Qiu
In this episode of Gradient Dissent, Kanjun Qiu, CEO and Co-founder of Imbue, joins host Lukas Biewald to discuss how AI agents are transforming code generation and software development. Discover the potential impact and challenges of creating autonomous AI systems that can write ... Show More
48m 37s
Jul 9
How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies ... Show More
31m 40s
May 2024
GSK’s Use of AI in Vaccine Tech, Drug Discovery
GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ... Show More
42m 42s
Oct 2023
DeepMind’s Latest AlphaFold AI Model Revolutionizing Drug Discovery
In this episode, we delve into how DeepMind's newest iteration of the AlphaFold model is revolutionizing the field of drug discovery. Explore the breakthroughs and potential applications that this cutting-edge technology brings to the pharmaceutical world. Invest in AI Box: h ... Show More
6m 34s
Dec 2024
The Economics of AI: A Conversation with Larry Summers
In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Larry Summers about artificial intelligence’s transformative potential and its implications for society. The conversation explores Summers’ perspective on AI as potentially the most significant tech ... Show More
38m 53s
Sep 2024
The Road to Autonomous Intelligence with Andrej Karpathy
Andrej Karpathy joins Sarah and Elad in this week of No Priors. Andrej, who was a founding team member of OpenAI and former Senior Director of AI at Tesla, needs no introduction. In this episode, Andrej discusses the evolution of self-driving cars, comparing Tesla and Waymo’s app ... Show More
44m 16s
Jun 13
HIGHLIGHTS: Ethan Mollick
We've curated a special 10-minute version of the podcast for those in a hurry. Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/ethan-mollick-ai-urgency-leadership-responsibility/id1614211565?i=1000712377483&l=nbWhich companies will lead and which wi ... Show More
10m 11s
Jul 2024
Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228
Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravi ... Show More
33m 11s
Dec 2024
Sam Altman's Equity Dilemma
In this episode of the AI Chat podcast, host Jaeden Schaefer discusses the controversies surrounding OpenAI, particularly focusing on Sam Altman's claims about his equity in the company. The conversation delves into Altman's testimony before Congress, the significant valuation gr ... Show More
14m 4s